These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 17804074

  • 1. New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents.
    Urquiola C, Gambino D, Cabrera M, Lavaggi ML, Cerecetto H, González M, de Cerain AL, Monge A, Costa-Filho AJ, Torre MH.
    J Inorg Biochem; 2008 Jan; 102(1):119-26. PubMed ID: 17804074
    [Abstract] [Full Text] [Related]

  • 2. Novel Cu(II) quinoxaline N1,N4-dioxide complexes as selective hypoxic cytotoxins.
    Torre MH, Gambino D, Araujo J, Cerecetto H, González M, Lavaggi ML, Azqueta A, López de Cerain A, Vega AM, Abram U, Costa-Filho AJ.
    Eur J Med Chem; 2005 May; 40(5):473-80. PubMed ID: 15893021
    [Abstract] [Full Text] [Related]

  • 3. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
    Vieites M, Noblía P, Torre MH, Cerecetto H, Laura Lavaggi M, Costa-Filho AJ, Azqueta A, de Cerain AL, Monge A, Parajón-Costa B, González M, Gambino D.
    J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.
    Urquiola C, Vieites M, Torre MH, Cabrera M, Lavaggi ML, Cerecetto H, González M, Cerain AL, Monge A, Smircich P, Garat B, Gambino D.
    Bioorg Med Chem; 2009 Feb 15; 17(4):1623-9. PubMed ID: 19162490
    [Abstract] [Full Text] [Related]

  • 5. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
    Buravchenko GI, Scherbakov AM, Dezhenkova LG, Bykov EE, Solovieva SE, Korlukov AA, Sorokin DV, Monzote Fidalgo L, Shchekotikhin AE.
    Bioorg Chem; 2020 Nov 15; 104():104324. PubMed ID: 33142432
    [Abstract] [Full Text] [Related]

  • 6. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
    Noblía P, Vieites M, Torre MH, Costa-Filho AJ, Cerecetto H, González M, Lavaggi ML, Adachi Y, Sakurai H, Gambino D.
    J Inorg Biochem; 2006 Feb 15; 100(2):281-7. PubMed ID: 16386797
    [Abstract] [Full Text] [Related]

  • 7. Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium.
    Urquiola C, Vieites M, Aguirre G, Marín A, Solano B, Arrambide G, Noblía P, Lavaggi ML, Torre MH, González M, Monge A, Gambino D, Cerecetto H.
    Bioorg Med Chem; 2006 Aug 15; 14(16):5503-9. PubMed ID: 16709457
    [Abstract] [Full Text] [Related]

  • 8. Revision of the Regioselectivity of the Beirut Reaction of Monosubstituted Benzofuroxans with Benzoylacetonitrile. 6-Substituted quinoxaline-2-carbonitrile 1,4- dioxides: Structural Characterization and Estimation of Anticancer Activity and Hypoxia Selectivity.
    Buravchenko GI, Scherbakov AM, Korlukov AА, Dorovatovskii PV, Shchekotikhin AE.
    Curr Org Synth; 2020 Aug 15; 17(1):29-39. PubMed ID: 32103715
    [Abstract] [Full Text] [Related]

  • 9. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
    Cerecetto H, González M, Risso M, Saenz P, Olea-Azar C, Bruno AM, Azqueta A, De Ceráin AL, Monge A.
    Arch Pharm (Weinheim); 2004 May 15; 337(5):271-80. PubMed ID: 15095420
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of 3-aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives as hypoxic selective anti-tumor agents.
    Hu Y, Xia Q, Shangguan S, Liu X, Hu Y, Sheng R.
    Molecules; 2012 Aug 13; 17(8):9683-96. PubMed ID: 22890172
    [Abstract] [Full Text] [Related]

  • 11. Syntheses and spectroscopic studies of potential antitumor copper(II) complexes with 5-phenylazo-3-methoxy salicylidene thiosemicarbazone and N4 substituted thiosemicarbazones.
    Patil BG, Havinale BR, Shallom JM, Chitnis MP.
    J Inorg Biochem; 1989 Jun 13; 36(2):107-13. PubMed ID: 2547893
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.
    Monge A, Palop JA, López de Ceráin A, Senador V, Martínez-Crespo FJ, Sainz Y, Narro S, García E, de Miguel C, González M.
    J Med Chem; 1995 May 12; 38(10):1786-92. PubMed ID: 7752202
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, crystal structure, cytotoxic and superoxide dismutase activities of copper(II) complexes of N-(4,5-dihydroimidazol-2-yl)azoles.
    Saczewski F, Dziemidowicz-Borys E, Bednarski PJ, Gdaniec M.
    Arch Pharm (Weinheim); 2007 Jul 12; 340(7):333-8. PubMed ID: 17611942
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, structure and biomimetic properties of Cu(II)-Cu(II) and Cu(II)-Zn(II) binuclear complexes: possible models for the chemistry of Cu-Zn superoxide dismutase.
    Patel RN, Singh N, Shukla KK, Gundla VL, Chauhan UK.
    J Inorg Biochem; 2005 Feb 12; 99(2):651-63. PubMed ID: 15621300
    [Abstract] [Full Text] [Related]

  • 15. Macrocyclic copper(II) complexes: superoxide scavenging activity, structural studies and cytotoxicity evaluation.
    Fernandes AS, Gaspar J, Cabral MF, Caneiras C, Guedes R, Rueff J, Castro M, Costa J, Oliveira NG.
    J Inorg Biochem; 2007 May 12; 101(5):849-58. PubMed ID: 17376531
    [Abstract] [Full Text] [Related]

  • 16. New quinoxalinecarbonitrile 1,4-di-N-oxide derivatives as hypoxic-cytotoxic agents.
    Ortega MA, Morancho MJ, Martínez-Crespo FJ, Sainz Y, Montoya ME, López de Ceráin A, Monge A.
    Eur J Med Chem; 2000 Jan 12; 35(1):21-30. PubMed ID: 10733600
    [Abstract] [Full Text] [Related]

  • 17. An efficient synthesis of quinoxaline derivatives from 4-chloro-4-deoxy-alpha-D-galactose and their cytotoxic activities.
    Yan L, Liu FW, Dai GF, Liu HM.
    Bioorg Med Chem Lett; 2007 Feb 01; 17(3):609-12. PubMed ID: 17110108
    [Abstract] [Full Text] [Related]

  • 18. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
    Amin KM, Ismail MM, Noaman E, Soliman DH, Ammar YA.
    Bioorg Med Chem; 2006 Oct 15; 14(20):6917-23. PubMed ID: 16843668
    [Abstract] [Full Text] [Related]

  • 19. Spectroscopic characterization of copper(II) complexes of indoxyl N(4)-methyl thiosemicarbazone.
    Chandra S, Kumar U.
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 Oct 15; 60(12):2825-9. PubMed ID: 15350918
    [Abstract] [Full Text] [Related]

  • 20. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
    Balakrishna MS, Suresh D, Rai A, Mague JT, Panda D.
    Inorg Chem; 2010 Oct 04; 49(19):8790-801. PubMed ID: 20812680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.